-
Something wrong with this record ?
Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats
J. Kriz, D. Jirak, T. Koblas, G. Vilk, P. Girman, M. Hajek, F. Saudek,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Biocompatible Materials MeSH
- Time Factors MeSH
- Diabetes Mellitus, Experimental pathology MeSH
- Gadolinium pharmacology MeSH
- Infusions, Intravenous MeSH
- Contrast Media pharmacology MeSH
- Rats MeSH
- Islets of Langerhans cytology MeSH
- Kidney metabolism MeSH
- Magnetic Resonance Imaging methods MeSH
- Organometallic Compounds pharmacology MeSH
- Software MeSH
- Tissue Scaffolds MeSH
- Islets of Langerhans Transplantation methods MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The transplantation of islets of Langerhans isolated from one donor pancreas can rarely release a diabetic recipient from insulin injections. The major reason is the destruction of 50%-60% of the transplanted tissue, which proceeds typically within a few hours after the insertion of the islets into the portal vein. Therefore, several groups have focused on development of an artificial site for islet transplantation. The main aim of the present study was to test the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate the blood supply feeding the artificially created cavities for islet transplantation. METHODS: Two rounded devices were implanted: one device subcutaneously and the second one into the greater omentum of each animal. On the day of implantation as well as 1, 3, and 4 weeks later, we quickly injected the vascular specific MR contrast agent Vasovist (0.05 mL/100 g) intravenously. Penetration of the contrast agent was monitored by DCE-MRI. The influence of the contrast agent on the signal intensity observed within selected target areas was calculated with the use of ImageJ software. RESULTS: The penetration of the contrast agent was detected by the increase in signal intensity within implanted devices. The signal increase caused by the contrast compound was normalized to kidney tissue. On day of implantation of the device, no signal due to the contrast agent was detected in all devices. However, over the following weeks, there was an increase in signal detection within the omental device to 34%, 21%, and 14% of that of the kidney. Within the subcutaneously implanted devices there was an increase in signal detection up to 11%, 10%, and 7% of that detected in the kidney. CONCLUSIONS: The optimal time for transplantation of pancreatic islets into our omental device was 1 week after implantation of the scaffold. Also, the blood supply feeding the subcutaneous devices was regarded to be inadequate.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008653
- 003
- CZ-PrNML
- 005
- 20150401101530.0
- 007
- ta
- 008
- 150306s2011 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.transproceed.2011.09.012 $2 doi
- 035 __
- $a (PubMed)22099763
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kriz, J $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. jkri@ikem.cz
- 245 10
- $a Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats / $c J. Kriz, D. Jirak, T. Koblas, G. Vilk, P. Girman, M. Hajek, F. Saudek,
- 520 9_
- $a BACKGROUND: The transplantation of islets of Langerhans isolated from one donor pancreas can rarely release a diabetic recipient from insulin injections. The major reason is the destruction of 50%-60% of the transplanted tissue, which proceeds typically within a few hours after the insertion of the islets into the portal vein. Therefore, several groups have focused on development of an artificial site for islet transplantation. The main aim of the present study was to test the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate the blood supply feeding the artificially created cavities for islet transplantation. METHODS: Two rounded devices were implanted: one device subcutaneously and the second one into the greater omentum of each animal. On the day of implantation as well as 1, 3, and 4 weeks later, we quickly injected the vascular specific MR contrast agent Vasovist (0.05 mL/100 g) intravenously. Penetration of the contrast agent was monitored by DCE-MRI. The influence of the contrast agent on the signal intensity observed within selected target areas was calculated with the use of ImageJ software. RESULTS: The penetration of the contrast agent was detected by the increase in signal intensity within implanted devices. The signal increase caused by the contrast compound was normalized to kidney tissue. On day of implantation of the device, no signal due to the contrast agent was detected in all devices. However, over the following weeks, there was an increase in signal detection within the omental device to 34%, 21%, and 14% of that of the kidney. Within the subcutaneously implanted devices there was an increase in signal detection up to 11%, 10%, and 7% of that detected in the kidney. CONCLUSIONS: The optimal time for transplantation of pancreatic islets into our omental device was 1 week after implantation of the scaffold. Also, the blood supply feeding the subcutaneous devices was regarded to be inadequate.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biokompatibilní materiály $7 D001672
- 650 _2
- $a kontrastní látky $x farmakologie $7 D003287
- 650 _2
- $a experimentální diabetes mellitus $x patologie $7 D003921
- 650 _2
- $a gadolinium $x farmakologie $7 D005682
- 650 _2
- $a intravenózní infuze $7 D007262
- 650 _2
- $a Langerhansovy ostrůvky $x cytologie $7 D007515
- 650 _2
- $a transplantace Langerhansových ostrůvků $x metody $7 D016381
- 650 _2
- $a ledviny $x metabolismus $7 D007668
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a organokovové sloučeniny $x farmakologie $7 D009942
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a software $7 D012984
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a tkáňové podpůrné struktury $7 D054457
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jirak, D
- 700 1_
- $a Koblas, T
- 700 1_
- $a Vilk, G
- 700 1_
- $a Girman, P
- 700 1_
- $a Hajek, M
- 700 1_
- $a Saudek, F
- 773 0_
- $w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 43, č. 9 (2011), s. 3226-30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22099763 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150401101800 $b ABA008
- 999 __
- $a ok $b bmc $g 1065926 $s 891453
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 43 $c 9 $d 3226-30 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
- LZP __
- $a Pubmed-20150306